VERA
VERA
US92337R1014
Vera Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.15B EUR
3.09B EUR
2.89B EUR
3.61B EUR
Enterprise Value
1.72B EUR
3.12B EUR
2.85B EUR
3.33B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.02x
--
--
--
Price to Sales
--
--
--
--
Price to Book
5.27x
7.57x
5.77x
5.97x
EV/Revenue
--
--
--
--
EV/EBITDA
-4.14x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.89%
-10.98%
-10.18%
-5.19%
ende